Article ID Journal Published Year Pages File Type
5687083 The Journal of Urology 2017 26 Pages PDF
Abstract
Silodosin, a pure α1A-adrenoceptor blocker, showed greater improvement in overactive bladder symptoms along with the urinary flow rate in patients with benign prostatic enlargement complicated by overactive bladder compared to naftopidil, an α1D>A-adrenoceptor blocker.
Related Topics
Health Sciences Medicine and Dentistry Nephrology
Authors
, , , , , , , ,